Duke scientists may have discovered a game-changing painkiller. SBI-810 is a new non-opioid drug that offers potent pain ...

Urinary tract infections are common and unpleasant, but a research team at Vanderbilt University has developed a ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

The team developed 5n, a potential prostate cancer inhibitor, to disrupt the disease's survival tactics through molecular ...

In 2025, benefits advisors must keep a close eye on key drug classes where biosimilar entry, indication expansion, and market momentum are changing the rules – and the costs – so they can help ...

First-in-class drugs are often considered a signifier of innovation in drug discovery; however, they can also carry substantial uncertainty. A new comparison of approval data for first-in-class drugs ...

Sunosi is a prescription drug that’s prescribed for excessive daytime sleepiness (EDS) in certain adults. It is a controlled substance. Sunosi is a part of the class of drugs called dopamine ...

Aaron S. Kesselheim, Brigham and Women’s Hospital and Harvard University. First-in-class drugs can be highly innovative because of their novel mechanisms of action, but they also carry ...

The government is considering reclassifying ketamine as a Class A substance after a record number of people reported using the drug. Ketamine is currently a Class B substance, meaning the maximum ...

The drug was developed by Karuna Therapeutics, which was bought by Bristol Myers Squibb (BMS) last year for $14 billion. This is the first new class of treatment for the psychiatric disorder since ...

UCSF scientists have discovered how to target a class of molecular switches called ... the GTPases have remained largely out of reach of modern drug discovery, with the exception of the notorious ...

Senate report finds "All drug classes are vulnerable to shortage," Dr. Paul Abramowitz, CEO of ASHP, said in a statement. "Some of the most worrying shortages involve generic sterile injectable ...